Beit Jala Pharmaceutical Company (PEX:BJP)

PEX:BJP Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25	20	20	20	19	18
Market Cap Growth	-	-	-1.75%	5.56%	5.88%	5.81%
Enterprise Value	23	20	19	21	21	20
Last Close Price	3.50	2.68	2.58	2.54	2.40	2.18
PE Ratio	8.96	11.16	10.67	10.07	21.70	23.95
PS Ratio	2.03	2.03	2.04	1.85	1.94	2.05
PB Ratio	1.34	1.27	1.34	1.51	1.52	1.49
P/TBV Ratio	1.34	1.27	1.34	1.51	1.52	1.49
P/FCF Ratio	14.55	89.61	29.24	7.09	70.56	-
P/OCF Ratio	4.96	21.66	10.13	6.20	17.36	9.29
EV/Sales Ratio	1.88	2.10	2.00	1.91	2.16	2.26
EV/EBITDA Ratio	3.98	7.78	5.89	6.22	9.94	9.90
EV/EBIT Ratio	6.97	10.53	8.90	8.73	19.01	18.60
EV/FCF Ratio	13.48	92.58	28.65	7.30	78.56	-
Debt / Equity Ratio	0.01	0.09	0.06	0.14	0.27	0.18
Debt / EBITDA Ratio	0.03	0.56	0.29	0.55	1.57	1.11
Debt / FCF Ratio	0.09	6.64	1.39	0.65	12.41	-
Asset Turnover	0.59	0.51	0.52	0.56	0.53	0.52
Inventory Turnover	2.04	1.94	2.02	2.26	2.64	2.94
Quick Ratio	4.03	2.07	2.49	1.60	1.18	1.77
Current Ratio	6.42	3.52	4.45	2.44	1.94	2.97
Return on Equity (ROE)	16.50%	11.70%	13.23%	15.45%	7.13%	6.18%
Return on Assets (ROA)	9.91%	6.30%	7.22%	7.60%	3.77%	3.92%
Return on Capital (ROIC)	11.75%	7.42%	8.83%	9.56%	4.62%	4.66%
Return on Capital Employed (ROCE)	16.30%	11.40%	13.30%	15.70%	7.60%	7.20%
Earnings Yield	11.09%	8.96%	9.37%	9.93%	4.61%	4.18%
FCF Yield	6.87%	1.12%	3.42%	14.11%	1.42%	-0.54%
Dividend Yield	3.43%	4.48%	3.87%	3.94%	4.16%	4.58%
Payout Ratio	30.91%	39.86%	38.10%	35.33%	80.36%	140.88%
Buyback Yield / Dilution	0.63%	-	-	-	-	-
Total Shareholder Return	4.06%	4.48%	3.87%	3.94%	4.16%	4.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.